Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion

RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT

(2016) Mary Ho et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Time to Clinically Significant Visual Acuity Gains after Ranibizumab Treatment for Retinal Vein Occlusion

(2014) Allen B. Thach et al.   OPHTHALMOLOGY

Monthly Versus As-Needed Ranibizumab Injections in Patients with Retinal Vein Occlusion

(2014) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Visual Acuity Outcome and Predictive Factors after Bevacizumab for Central Retinal Vein Occlusion

(2012) Vincent Daien et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

The burden of disease of retinal vein occlusion: review of the literature

(2011) M Laouri et al.   EYE

Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study

(2011) David M. Brown et al.   OPHTHALMOLOGY

Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study

(2011) Peter A. Campochiaro et al.   OPHTHALMOLOGY